Twin Focus Capital Partners, LLC Biogen Inc. Transaction History

Twin Focus Capital Partners, LLC

$625 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $13,487 - $15,584	49 Added 5.16%	999 $284,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $2,019 - $2,453	-8 Reduced 0.84%	950 $263,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $186,513 - $257,184	958 New	958 $256,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $180,038 - $214,099	-960 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $3,100 - $3,906	-16 Reduced 1.64%	960 $202,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $47,918 - $61,582	214 Added 28.08%	976 $234,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $282 - $369	1 Added 0.13%	762 $216,000
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $4,403 - $7,050	17 Added 2.28%	761 $264,000
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $180,754 - $211,764	744 New	744 $208,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $176,249 - $265,299	-746 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $197,518 - $228,059	746 New	746 $212,000
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $192,960 - $255,542	-746 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $15,593 - $19,780	58 Added 8.43%	746 $236,000
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $151,401 - $209,200	688 New	688 $204,000
Q3 2019 Nov 07, 2019	SELL	$217.44 - $243.88 $268,538 - $301,191	-1,235 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $108,355 - $169,480	500 Added 68.03%	1,235 $292,000
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $189,277 - $225,578	735 New	735 $213,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $184,432 - $260,848	-709 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $39,993 - $44,795	-130 Reduced 15.49%	709 $226,000
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $235,884 - $276,609	839	839 $263,000

Others Institutions Holding BIIB

# of Institutions

1,000

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Focus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Focus Capital Partners, LLC with notifications on news.

Account